Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type: Policy Paper

Filter Results By

Filter Applied. Clear All

Latest Posts

April 2, 2025 An Analysis of Colorado’s SB 25-183 An Analysis of Colorado’s SB 25-183 April 2, 2025 Filed: CLI Amicus Brief in Medina v. Planned Parenthood South Atlantic Filed: CLI Amicus Brief in Medina v. Planned Parenthood South Atlantic April 1, 2025 Filed: CLI Amicus Brief in National Institute of Family and Life Advocates v. James Filed: CLI Amicus Brief in National Institute of Family and Life Advocates v. James
Reset All Filters
Life & the Law

FDA Decision to Relax Chemical Abortion Rule Ignores the Science, Neglects Women, Places Them in Danger

"Our review of all the Adverse Events from mifepristone as an abortion drug revealed serious concerns about hemorrhage, infections, and fetal tissue left inside. There were over 500 life-threatening complications, which would have been deaths if the women had not had timely access to the Emergency Room. These women without access to an ER are exactly the women being targeted with abortions by mail, and those who are most at risk of death by patient abandonment. We know from other studies that reports from the FDA only represent a small fraction of the actual adverse events happening to women across the country."

Life & the Law

The Bold Finish of a Pro-Life Administration

This paper will explore some of the major pro-life gains made in the past four years, including those made in the final days of the Trump administration, and preview what may come in the days and weeks ahead.

Assisted Suicide’s Slippery Slope in Action: Washington State May Drop “Safeguards” Against Abuse
End of Life

Assisted Suicide’s Slippery Slope in Action: Washington State May Drop “Safeguards” Against Abuse

Opponents of physician-assisted suicide (PAS) have long warned that there is a “slippery slope” from initially limited acceptance of the practice to a broader “right” to take the lives of the sick and elderly. PAS supporters have generally dismissed this claim as alarmist. In my home state of Washington, however, supporters are now embracing the claim, and urging lawmakers to ski down the slope.

The “Equality Act”: Threatening Life and Equality
Life & the Law

The “Equality Act”: Threatening Life and Equality

Former vice-president Joseph Biden has made it clear that on becoming President, he hopes to advance his party’s stand on so-called “social issues” such as abortion and the LGBTQ agenda. His ability to do so will depend on whether he will be working with a Congress that shares his goals.

Abortion Cases in the Higher Federal Courts
Life & the Law

Abortion Cases in the Higher Federal Courts

Abortion advocates contend that the United States Supreme Court is on the precipice of reversing Roe v. Wade—the conservative justices are simply waiting for the arrival of another like-minded colleague, and they may find that person in Judge Amy Coney Barrett. An honest review of recent decisions by the Court, however, simply fails to support this belief. Instead of building a case for Roe’s demise, the Court has managed to make abortion jurisprudence even murkier for legislators and lower courts trying to determine the constitutionality of abortion laws, while otherwise refusing to make substantive decisions in abortion cases.

Federal Bioethics Commissions and Bias Against the Unborn
Fetal Tissue, Stem Cells & Bioethics

Federal Bioethics Commissions and Bias Against the Unborn

In August, the Trump administration’s new Human Fetal Tissue Research Ethics Advisory Board reviewed requests made to the National Institutes of Health (NIH) for federally funded fetal tissue research. The Board recommended denying most of these requests.

Maternal & Public Health

Medical and Social Risks Associated with Unmitigated Distribution of Mifepristone: A Primer

Chemical abortions, or “medication” abortions, have become a more prevalent method of abortion in recent years in the United States. In 2000, the Food and Drug Administration (FDA) approved the use of mifepristone, in conjunction with the drug misoprostol, as an abortion-inducing, two-drug process. By 2018, the Charlotte Lozier Institute estimates that 41% of U.S. abortions were chemically induced.

Abortion

New Abortion Trends in the United States: A First Look

Today Charlotte Lozier Institute (CLI), the research arm of the national pro-life group Susan B. Anthony List (SBA List), published a new report on emerging abortion trends in the United States. Ahead of the Centers for Disease Control and Prevention, as well as the Guttmacher Institute, CLI has the first analysis of trends revealed by the latest available state abortion reports from calendar year 2018

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image